Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 17/20 | 0.63 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.56 |
| ▸ | NPY1R | P25929 | 1/20 | 0.55 |
| ▸ | NPY2R | P49146 | 1/20 | 0.55 |
| ▸ | NPY4R | P50391 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30592736 | 0.94 | IL23R (0.62) | IL23RUTS2R | |
| SCHEMBL30537080 | 0.91 | UTS2R (0.56) | IL23RUTS2R | |
| SCHEMBL30368198 | 0.91 | NPY1R (0.56) | IL23RUTS2RNPY1RNPY2RNPY4R | |
| SCHEMBL29754573 | 0.90 | IL23R (0.62) | IL23RUTS2R | |
| SCHEMBL29440486 | 0.90 | NPBWR1 (0.58) | NPY1RNPY2RNPY4R | |
| SCHEMBL30636161 | 0.90 | NPBWR1 (0.58) | NPY1RNPY2RNPY4R | |
| SCHEMBL30272481 | 0.90 | KISS1R (0.57) | IL23RNPY1RNPY2RNPY4R | |
| SCHEMBL31511497 | 0.90 | NPY4R (0.58) | NPY1RNPY2RNPY4R | |
| SCHEMBL30529927 | 0.90 | KISS1R (0.58) | IL23RNPY1RNPY2RNPY4R | |
| SCHEMBL31206256 | 0.89 | KISS1R (0.55) | IL23RNPY1RNPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11628202-B2 | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia | NYMOX CORPORATION (CA) | 2023-04-18 | — | — | US | disclosed |